References
- Van Hooff, J.P., Boots, M., van Duijnhoven, E.M., Christiaans, M.H. Dosing and management guidelines for tacrolimus in renal transplant patients. Transplant Proc 1999; 31(7A): 54S–57S.
- Peters, D.H., Fitton, A., Plosker, G.L., Faulds, D. Tacrolimus: a review of its pharmacology and therapeutic potential in hepatic and renal transplantation. Drugs 1993; 46(4): 746–794.
- Liu, J., Wang, Y.P., Liu, H.Z. Research progress of the chemical components and the pharmacology of schisandra chinensis. Spec Wild Econ Animal Plant Res2005; 3(27): 49–53.
- Fu, M., Sun, Z.H., Zong, M., et al. Deoxyschisandrin modulates synchronized Ca2+ oscillations and spontaneous synaptic transmission of cultured hippocampal neurons. Acta Pharmacol Sin 2008; 29 (8): 891–898.
- Nakajima, K., Taguchi, H., Ikeya, Y., et al. Constituents of Schizandra chinensis Baill. XIII. Quantitative analysis of lignans in the fruits of Schizandra chinensis Baill by high performance liquid chromatography. Yakugaku Zasshi. 1983; 103(7): 743–749.
- Venkataramanan, R., Swaminathan, A., Prasad, T., et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 1995; 29 (6): 404–430.
- Saitoh, H., Saikachi, Y., Kobayashi, M., et al. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine. Eur J Pharm Sci. 2006;28(1–2): 34–42.